hotspot -WSS

hotspot

author：leisure time 2025-09-03 15:18:57 - browse：3959

Paul Biondi Flagship

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies.

Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties. Flagship’s portfolio companies will also share in any payments that come out of the partnership.

Flagship has historically developed new medicines by forming and spinning out startup companies, some of which have signed their own collaboration deals with the likes of Amgen or Nestlé Health Science. But in recent years, the firm has been pursuing external partnerships through a new business division called Pioneering Medicines, led by former Bristol Myers Squibb executive Paul Biondi. Pioneering Medicines uses technologies and other scientific platforms being developed by Flagship’s portfolio companies to look for possible therapies in disease areas that the startup may not be working in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： New study raises questions about niacin and heart health

hotspot

WSS

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Flagship Pioneering startup Sonata Therapeutics lays off 21

New study raises questions about niacin and heart health

At JPM 2024, hospital systems pitch financial strength to investors

Medicare Advantage coverage denials need scrutiny, senators say

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

entertainment

hotspot

focus

Moonlake's readout produced a cash windfall. Risks remain

Allen Institute goes after foundational questions, CEO Costa says

How to save PrEP access — and even expand it

FDA warns medical device makers about rise in fabricated data

Continuity nursing helped my family in our darkest PICU moments

Physician assistants need a new name. Here's what it should be

At least 13 dead in Texas as scorching temps continue

STAT Virtual Event: JPM Recap, Live!

Medical leaders decry Supreme Court decision on affirmative action

Ascension's ugly legal battle over care for poor patients in Texas

knowledge

Measles policy set amid Florida outbreak alarms vaccine proponents

Medicare Advantage overpayments discussion gets experts fired up

FDA early review: GLP

Fauci's latest grilling in Congress: 9 hours, behind closed doors

New study raises questions about niacin and heart health

New study raises questions about niacin and heart health

hotspot

hotspot

hotspot

entertainment